DVA Davita Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 60
Relative Strength: Rel. Strength: 19
Relative Valuation: Rel. Valuation: 85
Relative Profitability: Rel. Profitability: 39

EPS in 2025 (TTM): $9.92

Last Report Period Date: Sep 30, 2025

Based on the company's latest reports for September 2025, the current 12-month EPS is $9.92. Davita's earnings per share in 2024 was reported at $11.02, marking a rise from $7.62 in 2023. In the quarterly report ending on Sep 30, 2025, DVA's earnings per share amounted to $2.09.

DVA earnings history

Historical annual and quarterly earnings per share (EPS) data for Davita
EPS (TTM)
$9.92
EPS Growth YoY (Quarterly)
-18.4%
EPS (Quarterly)
$2.09
EPS Growth (Quarterly)
-20.2%

Davita had an yealy earnings per share of $11.02, showing a rise of 44.6% from $7.62 recorded in 2023. The quarterly earnings per share for the period ending Sep 30, 2025, was $2.09, showing a 18.4% decline compared to the same quarter last year. The trailing twelve months EPS for DVA is $9.92 as of September 2025. Davita's full-year EPS for 2023 was $7.62, a 26.4% rise compared to the previous year.

DVA EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-18.4%
EPS growth YoY
44.6%
EPS growth 3Y avg
5.8%
EPS growth 5Y avg
15.8%

In the past 12 months, Davita has recorded an earnings per share growth rate of -18.4% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 5.8% per year. In the last five years, the company had an average annual EPS growth of 15.8%. When assessed over a ten-year period, DVA's average EPS annual growth was 12.4%.

DVA Earnings Waterfall

Breakdown of revenue, profit and net income for Davita

DVA Earnings vs Peers

What are the earnings of DVA compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
MD Mednax Inc 11.21 -63% N/A N/A
UHS Universal Health Services Inc 11.69 65.8% 12.7% 13.4%
DVA Davita Inc 12.21 44.6% 5.8% 15.8%
THC Tenet Healthcare Corp 13.8 449.4% 56.9% N/A
LH Laboratory Corp Of America Holdings 24.03 85.2% -28.8% 1.1%

All data is based on quarterly TTM periods, unless otherwise specified.